Moreover, the expression of 5'UTR TRPV1 variants in GBM, glioma stem-like cells (GSCs) and the 5'UTR TRPV1 variants role as prognostic factor in the survival of GBM patients have been evaluated. This evidence concerns the gene TRPV1 and central nervous system cancer.